Popović, L.; Borštnar, S.; Božović-Spasojević, I.; Cvetanović, A.; Dedić Plavetić, N.; Kaneva, R.; Konsoulova, A.; Matos, E.; Tomić, S.; Vrdoljak, E.
Treatment Sequencing in Metastatic HR+/HER2− Breast Cancer: A Delphi Consensus. Cancers 2025, 17, 1412.
https://doi.org/10.3390/cancers17091412
AMA Style
Popović L, Borštnar S, Božović-Spasojević I, Cvetanović A, Dedić Plavetić N, Kaneva R, Konsoulova A, Matos E, Tomić S, Vrdoljak E.
Treatment Sequencing in Metastatic HR+/HER2− Breast Cancer: A Delphi Consensus. Cancers. 2025; 17(9):1412.
https://doi.org/10.3390/cancers17091412
Chicago/Turabian Style
Popović, Lazar, Simona Borštnar, Ivana Božović-Spasojević, Ana Cvetanović, Natalija Dedić Plavetić, Radka Kaneva, Assia Konsoulova, Erika Matos, Snježana Tomić, and Eduard Vrdoljak.
2025. "Treatment Sequencing in Metastatic HR+/HER2− Breast Cancer: A Delphi Consensus" Cancers 17, no. 9: 1412.
https://doi.org/10.3390/cancers17091412
APA Style
Popović, L., Borštnar, S., Božović-Spasojević, I., Cvetanović, A., Dedić Plavetić, N., Kaneva, R., Konsoulova, A., Matos, E., Tomić, S., & Vrdoljak, E.
(2025). Treatment Sequencing in Metastatic HR+/HER2− Breast Cancer: A Delphi Consensus. Cancers, 17(9), 1412.
https://doi.org/10.3390/cancers17091412